nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—SLC22A2—Abacavir transmembrane transport—ABCB1—adrenal gland cancer	0.0432	0.0432	CbGpPWpGaD
Memantine—GRIN2A—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.0271	0.0271	CbGpPWpGaD
Memantine—SLC22A2—Abacavir transport and metabolism—ABCB1—adrenal gland cancer	0.0248	0.0248	CbGpPWpGaD
Memantine—GRIN2A—Post NMDA receptor activation events—PRKACA—adrenal gland cancer	0.0241	0.0241	CbGpPWpGaD
Memantine—GRIN1—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.0236	0.0236	CbGpPWpGaD
Memantine—GRIN2B—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.023	0.023	CbGpPWpGaD
Memantine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—PRKACA—adrenal gland cancer	0.0222	0.0222	CbGpPWpGaD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0217	0.0217	CbGpPWpGaD
Memantine—GRIN1—Post NMDA receptor activation events—PRKACA—adrenal gland cancer	0.021	0.021	CbGpPWpGaD
Memantine—GRIN2B—Post NMDA receptor activation events—PRKACA—adrenal gland cancer	0.0205	0.0205	CbGpPWpGaD
Memantine—CYP2A6—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.0202	0.0202	CbGpPWpGaD
Memantine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—PRKACA—adrenal gland cancer	0.0194	0.0194	CbGpPWpGaD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0189	0.0189	CbGpPWpGaD
Memantine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—PRKACA—adrenal gland cancer	0.0189	0.0189	CbGpPWpGaD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0185	0.0185	CbGpPWpGaD
Memantine—GRIN1—EPHB-mediated forward signaling—CDC42—adrenal gland cancer	0.0164	0.0164	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0163	0.0163	CbGpPWpGaD
Memantine—GRIN2B—EPHB-mediated forward signaling—CDC42—adrenal gland cancer	0.016	0.016	CbGpPWpGaD
Memantine—GRIN2A—CREB phosphorylation through the activation of Ras—BRAF—adrenal gland cancer	0.0158	0.0158	CbGpPWpGaD
Memantine—DRD2—Nicotine Activity on Dopaminergic Neurons—PRKACA—adrenal gland cancer	0.0152	0.0152	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0142	0.0142	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0139	0.0139	CbGpPWpGaD
Memantine—GRIN1—CREB phosphorylation through the activation of Ras—BRAF—adrenal gland cancer	0.0138	0.0138	CbGpPWpGaD
Memantine—GRIN2B—CREB phosphorylation through the activation of Ras—BRAF—adrenal gland cancer	0.0134	0.0134	CbGpPWpGaD
Memantine—GRIN2A—Post NMDA receptor activation events—BRAF—adrenal gland cancer	0.013	0.013	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—KCNJ5—adrenal gland cancer	0.0125	0.0125	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.0124	0.0124	CbGpPWpGaD
Memantine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—adrenal gland cancer	0.012	0.012	CbGpPWpGaD
Memantine—GRIN1—Post NMDA receptor activation events—BRAF—adrenal gland cancer	0.0113	0.0113	CbGpPWpGaD
Memantine—GRIN2B—Post NMDA receptor activation events—BRAF—adrenal gland cancer	0.0111	0.0111	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—KCNJ5—adrenal gland cancer	0.0109	0.0109	CbGpPWpGaD
Memantine—DRD2—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.0108	0.0108	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—KCNJ5—adrenal gland cancer	0.0106	0.0106	CbGpPWpGaD
Memantine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—adrenal gland cancer	0.0104	0.0104	CbGpPWpGaD
Memantine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—adrenal gland cancer	0.0102	0.0102	CbGpPWpGaD
Memantine—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00897	0.00897	CbGpPWpGaD
Memantine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—adrenal gland cancer	0.00855	0.00855	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—CDC42—adrenal gland cancer	0.00847	0.00847	CbGpPWpGaD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00832	0.00832	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—CDC42—adrenal gland cancer	0.00825	0.00825	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.008	0.008	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—BAD—adrenal gland cancer	0.00779	0.00779	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0074	0.0074	CbGpPWpGaD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00726	0.00726	CbGpPWpGaD
Memantine—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00724	0.00724	CbGpPWpGaD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00708	0.00708	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—CDC42—adrenal gland cancer	0.00706	0.00706	CbGpPWpGaD
Memantine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.0069	0.0069	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—BAD—adrenal gland cancer	0.00679	0.00679	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00666	0.00666	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—BAD—adrenal gland cancer	0.00662	0.00662	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00626	0.00626	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—NR5A1—adrenal gland cancer	0.00604	0.00604	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—CDC42—adrenal gland cancer	0.00602	0.00602	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—NR5A1—adrenal gland cancer	0.00589	0.00589	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—CDC42—adrenal gland cancer	0.00587	0.00587	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—KCNJ5—adrenal gland cancer	0.00567	0.00567	CbGpPWpGaD
Memantine—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00547	0.00547	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00546	0.00546	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00532	0.00532	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—PRKACA—adrenal gland cancer	0.00479	0.00479	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00457	0.00457	CbGpPWpGaD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00448	0.00448	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—RB1—adrenal gland cancer	0.00441	0.00441	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—BAD—adrenal gland cancer	0.0042	0.0042	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—PRKACA—adrenal gland cancer	0.00418	0.00418	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—BAD—adrenal gland cancer	0.0041	0.0041	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—PRKACA—adrenal gland cancer	0.00408	0.00408	CbGpPWpGaD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00391	0.00391	CbGpPWpGaD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00381	0.00381	CbGpPWpGaD
Memantine—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00372	0.00372	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MED12—adrenal gland cancer	0.00363	0.00363	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.00362	0.00362	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MED12—adrenal gland cancer	0.00354	0.00354	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00348	0.00348	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—TP53—adrenal gland cancer	0.00341	0.00341	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00337	0.00337	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—CDC42—adrenal gland cancer	0.00315	0.00315	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00312	0.00312	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—CDC42—adrenal gland cancer	0.00307	0.00307	CbGpPWpGaD
Memantine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00302	0.00302	CbGpPWpGaD
Memantine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.003	0.003	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—TP53—adrenal gland cancer	0.00297	0.00297	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00294	0.00294	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—TP53—adrenal gland cancer	0.0029	0.0029	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00287	0.00287	CbGpPWpGaD
Memantine—CYP2A6—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.00285	0.00285	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00284	0.00284	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00283	0.00283	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.00276	0.00276	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00274	0.00274	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.0027	0.0027	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.00269	0.00269	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00259	0.00259	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—BRAF—adrenal gland cancer	0.00258	0.00258	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—EGFR—adrenal gland cancer	0.00257	0.00257	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00244	0.00244	CbGpPWpGaD
Memantine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00244	0.00244	CbGpPWpGaD
Memantine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00227	0.00227	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—BRAF—adrenal gland cancer	0.00225	0.00225	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—CDC42—adrenal gland cancer	0.00225	0.00225	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—BRAF—adrenal gland cancer	0.0022	0.0022	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00219	0.00219	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—CDC42—adrenal gland cancer	0.00219	0.00219	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—PRKACA—adrenal gland cancer	0.00217	0.00217	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TP53—adrenal gland cancer	0.00216	0.00216	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00215	0.00215	CbGpPWpGaD
Memantine—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.0021	0.0021	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00208	0.00208	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00196	0.00196	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00186	0.00186	CbGpPWpGaD
Memantine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00184	0.00184	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00178	0.00178	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00178	0.00178	CbGpPWpGaD
Memantine—CYP2A6—Biological oxidations—POMC—adrenal gland cancer	0.0016	0.0016	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SDHB—adrenal gland cancer	0.00156	0.00156	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00153	0.00153	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SDHB—adrenal gland cancer	0.00143	0.00143	CbGpPWpGaD
Memantine—CYP2B6—Biological oxidations—POMC—adrenal gland cancer	0.00129	0.00129	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.0012	0.0012	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00118	0.00118	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—BRAF—adrenal gland cancer	0.00117	0.00117	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00117	0.00117	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SDHB—adrenal gland cancer	0.00116	0.00116	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—EGFR—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—EGFR—adrenal gland cancer	0.00112	0.00112	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00108	0.00108	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00107	0.00107	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—CTNNB1—adrenal gland cancer	0.00103	0.00103	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—RRM1—adrenal gland cancer	0.00101	0.00101	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SDHD—adrenal gland cancer	0.00101	0.00101	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—CTNNB1—adrenal gland cancer	0.00101	0.00101	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00098	0.00098	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.000978	0.000978	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000955	0.000955	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000953	0.000953	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000947	0.000947	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000943	0.000943	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000929	0.000929	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—RRM1—adrenal gland cancer	0.000924	0.000924	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SDHD—adrenal gland cancer	0.000924	0.000924	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000921	0.000921	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.000874	0.000874	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—EGFR—adrenal gland cancer	0.000817	0.000817	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—EGFR—adrenal gland cancer	0.000796	0.000796	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—MED12—adrenal gland cancer	0.00075	0.00075	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—RRM1—adrenal gland cancer	0.000745	0.000745	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SDHD—adrenal gland cancer	0.000745	0.000745	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—POMC—adrenal gland cancer	0.000727	0.000727	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—MED12—adrenal gland cancer	0.000689	0.000689	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000688	0.000688	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000684	0.000684	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	0.000646	0.000646	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000639	0.000639	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000631	0.000631	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00061	0.00061	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00058	0.00058	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000578	0.000578	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.000563	0.000563	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.000563	0.000563	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	0.000563	0.000563	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—MED12—adrenal gland cancer	0.000556	0.000556	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000554	0.000554	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PRKACA—adrenal gland cancer	0.000547	0.000547	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	0.000529	0.000529	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PRKACA—adrenal gland cancer	0.000502	0.000502	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GNAS—adrenal gland cancer	0.000444	0.000444	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ABCB1—adrenal gland cancer	0.000435	0.000435	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.00042	0.00042	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000411	0.000411	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GNAS—adrenal gland cancer	0.000407	0.000407	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	0.000405	0.000405	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000404	0.000404	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ABCB1—adrenal gland cancer	0.0004	0.0004	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000375	0.000375	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	0.000373	0.000373	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	0.000343	0.000343	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	0.00033	0.00033	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GNAS—adrenal gland cancer	0.000329	0.000329	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	0.000327	0.000327	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	0.000322	0.000322	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000319	0.000319	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	0.000306	0.000306	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000299	0.000299	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—POMC—adrenal gland cancer	0.000299	0.000299	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TERT—adrenal gland cancer	0.000275	0.000275	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—POMC—adrenal gland cancer	0.000274	0.000274	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GNAS—adrenal gland cancer	0.000248	0.000248	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	0.000244	0.000244	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BAD—adrenal gland cancer	0.000239	0.000239	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—adrenal gland cancer	0.000238	0.000238	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—POMC—adrenal gland cancer	0.000221	0.000221	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—POMC—adrenal gland cancer	0.00022	0.00022	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—adrenal gland cancer	0.000219	0.000219	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	0.000218	0.000218	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000211	0.000211	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	0.000176	0.000176	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—POMC—adrenal gland cancer	0.000167	0.000167	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000157	0.000157	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	0.000133	0.000133	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	0.000125	0.000125	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—adrenal gland cancer	0.000105	0.000105	CbGpPWpGaD
